| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Departamento de Morfología y Biología Celular and
Departamento de Biología Funcional, Facultad de Medicina, Oviedo, Spain; and
Department of Cell and Structural Biology, University of Texas Health Science Center at San Antonio, Texas, USA
1Correspondence: Departamento de Morfología y Biología Celular, Facultad de Medicina, Julian Claveria 33006 Oviedo, Spain. E-mail: carro{at}sci.cpd.uniovi.es
We have previouslyreported that low doses of melatonin inhibit apoptosis in both dexamethasone-treated cultured thymocytes (standard model for the study of apoptosis) and the intact thymus. Here we elucidate the mechanism by which this agent protects thymocytes from cell death induced by glucocorticoids. Our results demonstrate an effect of melatonin on the mRNA for antioxidant enzymes in thymocytes, also showing an unexpected regulation by dexamethasone of these mRNA. Both an effect of melatonin on the general machinery of apoptosis and a possible regulation of the expression of the cell death related genes bcl-2 and p53 are shown not to be involved. We found melatonin to down-regulate the mRNA for the glucocorticoid receptor in thymocytes (glucocorticoids up-regulate their own receptor). The decrease by melatonin of mRNA levels for this receptor in IM-9 cells (where glucocorticoids down-regulate it) demonstrates that melatonin actually down-regulates glucocorticoid receptor. These findings allow us to propose the effects of melatonin on this receptor as the likely mediator of its thymocyte protection against dexamethasone-induced cell death. This effect of melatonin, given the oxidant properties of glucocorticoids, adds another mechanism to explain its antioxidant effects.—Sainz, R. M., Mayo, J. C., Reiter, R. J., Antolín, I., Esteban, M. M., Rodríguez, C. Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus.
Key Words: antioxidant enzymes • glucocorticoids • apoptosis • DNA fragmentation
This article has been cited by other articles:
|
|
 |
|
  F. RADOGNA, L. PATERNOSTER, M. C. ALBERTINI, A. ACCORSI, C. CERELLA, M. D'ALESSIO, M. DE NICOLA, S. NUCCITELLI, A. MAGRINI, A. BERGAMASCHI, et al. Melatonin as an Apoptosis Antagonist Ann. N.Y. Acad. Sci., December 1, 2006; 1090(1): 226 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Presman, E. Hoijman, N. R. Ceballos, M. D. Galigniana, and A. Pecci Melatonin Inhibits Glucocorticoid Receptor Nuclear Translocation in Mouse Thymocytes Endocrinology, November 1, 2006; 147(11): 5452 - 5459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Cutolo and G J M Maestroni The melatonin-cytokine connection in rheumatoid arthritis Ann Rheum Dis, August 1, 2005; 64(8): 1109 - 1111. [Full Text] [PDF]
|
|
|
|
|
|
E. Hoijman, L. Rocha Viegas, M. I. Keller Sarmiento, R. E. Rosenstein, and A. Pecci Involvement of Bax Protein in the Prevention of Glucocorticoid-Induced Thymocytes Apoptosis by Melatonin Endocrinology, January 1, 2004; 145(1): 418 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. N. Anisimov Effects of Exogenous Melatonin--A Review Toxicol Pathol, October 1, 2003; 31(6): 589 - 603. [Abstract] [PDF]
|
|
|
|
 |
|
 K. H. Maclean, J. L. Cleveland, and J. B. Porter Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes Blood, December 15, 2001; 98(13): 3831 - 3839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Savino and M. Dardenne Neuroendocrine Control of Thymus Physiology Endocr. Rev., August 1, 2000; 21(4): 412 - 443. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
